HedgePath Pharmaceuticals, Inc. (12)

Browse by Contract Category

Contracts

Stipulation and Agreement of Compromise, Settlement, and Release, dated September 9, 2022 (Filed With SEC on December 19, 2022)
License Agreement by and between the Company and Mayne, dated December 13, 2022 (Filed With SEC on December 19, 2022)
Employment Agreement by and between the Company and Francis E. ODonnell, dated December 13, 2022 (Filed With SEC on December 19, 2022)
Letter Agreement to Amend Term Debt Facility, dated March 9, 2022, between the Company and Mayne Pharma (Filed With SEC on March 30, 2022)
Sublicense Agreement, dated August 27, 2019, by and between Mayne Pharma International Pty Ltd and the Company (Certain information has been redacted in the marked portions of the... (Filed With SEC on November 7, 2019)
Employment Agreement by and between the Company and James A. McNulty, dated December 13, 2022 (Filed With SEC on December 19, 2022)
Letter Agreement to Amend Term Debt Facility, dated January 13, 2022, between the Company and Mayne Pharma (Filed With SEC on January 18, 2022)
Letter Agreement for Term Debt Facility, dated December 12, 2020, between the Company and Mayne Pharma (Filed With SEC on December 17, 2020)
Promissory Note, dated May 2, 2020, by and between the Company and Citibank, N.A (Filed With SEC on May 6, 2020)
Amended and Restated Sublicense Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)
Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)
Third Amended and Restated Supply and License Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)